
Clinical trial helps treat woman’s “insufferable pain” from sunlight
A woman with a rare condition that causes insufferable pain from sunlight finds relief through a clinical trial for a new drug.


A woman with a rare condition that causes insufferable pain from sunlight finds relief through a clinical trial for a new drug.

Eli Lilly's combo of Zepbound and amylin-targeting eloralintide yields 23.3% weight loss in mid-stage trial, though tolerability woes loom.

New obesity drug trial shows 25% weight loss at 80 weeks, rising to 30% at 104 weeks, with major health benefits.

UniQure's gene therapy slows Huntington's progression for four years, but data lacks statistical significance ahead of FDA review.

An infusion silenced a gene, and bad fat vanished from the blood for a year, whole and entire.

A rival drug's failure sent Amgen's share price tumbling, casting doubt upon the very hypothesis its own late-stage asset relies upon.

A drug derived from LSD shows promise for anxiety, easing distress in a second large trial.
As an Amazon Associate, Clay Tribune earns from qualifying purchases.